BRPI0922041A2 - formulações compreendendo ceftiofur e cetoprofeno ou cetiofur e álcool benzílico. - Google Patents
formulações compreendendo ceftiofur e cetoprofeno ou cetiofur e álcool benzílico.Info
- Publication number
- BRPI0922041A2 BRPI0922041A2 BRPI0922041A BRPI0922041A BRPI0922041A2 BR PI0922041 A2 BRPI0922041 A2 BR PI0922041A2 BR PI0922041 A BRPI0922041 A BR PI0922041A BR PI0922041 A BRPI0922041 A BR PI0922041A BR PI0922041 A2 BRPI0922041 A2 BR PI0922041A2
- Authority
- BR
- Brazil
- Prior art keywords
- cetiofur
- ceftiofur
- ketoprofen
- formulations
- benzyl alcohol
- Prior art date
Links
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 title 3
- 235000019445 benzyl alcohol Nutrition 0.000 title 1
- ZBHXIWJRIFEVQY-IHMPYVIRSA-N ceftiofur Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC(=O)C1=CC=CO1 ZBHXIWJRIFEVQY-IHMPYVIRSA-N 0.000 title 1
- 229960005229 ceftiofur Drugs 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 title 1
- 229960000991 ketoprofen Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Dispersion Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11603108P | 2008-11-19 | 2008-11-19 | |
US11976408P | 2008-12-04 | 2008-12-04 | |
PCT/US2009/064978 WO2010059717A2 (en) | 2008-11-19 | 2009-11-18 | Formulations comprising ceftiofur and ketoprofen or ceftiofur and benzyl alcohol |
Publications (2)
Publication Number | Publication Date |
---|---|
BRPI0922041A2 true BRPI0922041A2 (pt) | 2015-12-22 |
BRPI0922041A8 BRPI0922041A8 (pt) | 2022-08-16 |
Family
ID=41682851
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0922041A BRPI0922041A8 (pt) | 2008-11-19 | 2009-11-18 | Formulações compreendendo ceftiofur e cetoprofeno ou cetiofur e álcool benzílico. |
Country Status (15)
Country | Link |
---|---|
US (1) | US20100125060A1 (pt) |
EP (1) | EP2367572B1 (pt) |
JP (1) | JP5685193B2 (pt) |
KR (1) | KR101748890B1 (pt) |
CN (1) | CN102341125B (pt) |
AU (1) | AU2009316708B2 (pt) |
BR (1) | BRPI0922041A8 (pt) |
CA (1) | CA2743551C (pt) |
CL (1) | CL2011001177A1 (pt) |
CO (1) | CO6390043A2 (pt) |
ES (1) | ES2693700T3 (pt) |
MX (1) | MX2011005217A (pt) |
NZ (1) | NZ592984A (pt) |
WO (1) | WO2010059717A2 (pt) |
ZA (1) | ZA201103479B (pt) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2477590A (en) * | 2010-02-05 | 2011-08-10 | Biocopea Ltd | A non-steroidal anti-inflammatory drug (NSAID) formulation comprising a lipid carrier |
US9504664B2 (en) | 2010-10-29 | 2016-11-29 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
US11224659B2 (en) | 2010-10-29 | 2022-01-18 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
US9744132B2 (en) | 2010-10-29 | 2017-08-29 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
US9737500B2 (en) | 2010-10-29 | 2017-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
US11730709B2 (en) | 2010-10-29 | 2023-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
US10695431B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
US9271950B2 (en) | 2010-10-29 | 2016-03-01 | Infirst Healthcare Limited | Compositions for treating chronic inflammation and inflammatory diseases |
US9308213B2 (en) | 2010-10-29 | 2016-04-12 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
US8895537B2 (en) | 2010-10-29 | 2014-11-25 | Infirst Healthcare Ltd. | Compositions and methods for treating cardiovascular diseases |
US10695432B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
GB201018289D0 (en) * | 2010-10-29 | 2010-12-15 | Biocopea Ltd | Treatment of respiratory disorders |
US11202831B2 (en) | 2010-10-29 | 2021-12-21 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
AR090775A1 (es) * | 2012-04-23 | 2014-12-03 | Otsuka Pharma Co Ltd | Preparado inyectable |
ES2682761T3 (es) | 2012-05-18 | 2018-09-21 | Genentech, Inc. | Formulaciones de anticuerpos monoclonales de alta concentración |
UY34913A (es) * | 2012-07-17 | 2013-12-31 | Bayer New Zealand Ltd | Formaciones inyectables de antibiótico y sus métodos de aplicación |
FR3000392B1 (fr) | 2012-12-27 | 2015-03-27 | Virbac | Nouvelles compositions pharmaceutiques veterinaires et leur procede de preparation |
KR101586789B1 (ko) * | 2012-12-28 | 2016-01-19 | 주식회사 종근당 | 양이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
KR101586791B1 (ko) | 2012-12-28 | 2016-01-19 | 주식회사 종근당 | GnRH 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
DK3082762T3 (da) * | 2013-12-16 | 2021-12-06 | Zoetis Services Llc | Langtidsvirkende ketoprofensammensætninger |
WO2017119928A1 (en) * | 2016-01-08 | 2017-07-13 | Abon Pharmaceuticals, Llc | Long acting injectable formulations |
CN107049943B (zh) * | 2017-05-10 | 2020-02-14 | 郑州百瑞动物药业有限公司 | 奶牛用盐酸头孢噻呋注射液及其制备方法 |
JP7323630B2 (ja) * | 2019-03-06 | 2023-08-08 | ゾエティス・サービシーズ・エルエルシー | 使用準備が整った注射用製剤 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1181672B (it) * | 1984-10-25 | 1987-09-30 | Upjohn Co | Cefalosporina alogenidrato cristallino |
DE3887691T2 (de) * | 1987-11-10 | 1994-06-09 | Upjohn Co | Cephalosporin-antibiotika. |
ATE202109T1 (de) * | 1993-03-12 | 2001-06-15 | Upjohn Co | Kristallines ceftiofur (freie säure) |
US5736151A (en) * | 1996-12-09 | 1998-04-07 | Pharmacia & Upjohn Company | Antibiotic oil suspensions |
US6074657A (en) * | 1997-03-20 | 2000-06-13 | Pharmacia & Upjohn Company | Administration of an injectable antibiotic in the ear of an animal |
JP2004504357A (ja) * | 2000-07-26 | 2004-02-12 | アルコン,インコーポレイテッド | ポリマー性懸濁化剤を含有しない薬学的懸濁組成物 |
AU2001288322A1 (en) * | 2000-09-12 | 2002-03-26 | Pharmacia And Upjohn Company Llc | Pharmaceutical composition having specific water activity |
CA2416566C (en) * | 2000-09-12 | 2011-05-31 | Pharmacia & Upjohn Company | Depot formulation comprising ceftiofur and peroxidized natural oil |
KR100423895B1 (ko) * | 2001-02-19 | 2004-03-24 | 주식회사 엘지생명과학 | 셉티오퍼 하이드로클로라이드의 현탁제 조성물 |
US20040022815A1 (en) * | 2002-08-05 | 2004-02-05 | Orchid Health Care | Novel pharmaceutical composition of ceftiofur |
KR20040015622A (ko) * | 2002-08-13 | 2004-02-19 | 대한뉴팜(주) | 세프티오푸르나트륨을 활성성분으로 함유하는 현탁주사액조성물 |
CN100534433C (zh) * | 2005-12-12 | 2009-09-02 | 浙江升华拜克生物股份有限公司 | 一种含头孢噻呋的兽用粉针注射剂 |
-
2009
- 2009-11-18 KR KR1020117014061A patent/KR101748890B1/ko active IP Right Grant
- 2009-11-18 JP JP2011537581A patent/JP5685193B2/ja active Active
- 2009-11-18 US US12/621,208 patent/US20100125060A1/en not_active Abandoned
- 2009-11-18 CN CN200980152552.1A patent/CN102341125B/zh active Active
- 2009-11-18 BR BRPI0922041A patent/BRPI0922041A8/pt not_active Application Discontinuation
- 2009-11-18 CA CA2743551A patent/CA2743551C/en active Active
- 2009-11-18 ES ES09764376.1T patent/ES2693700T3/es active Active
- 2009-11-18 NZ NZ592984A patent/NZ592984A/xx unknown
- 2009-11-18 EP EP09764376.1A patent/EP2367572B1/en active Active
- 2009-11-18 WO PCT/US2009/064978 patent/WO2010059717A2/en active Application Filing
- 2009-11-18 MX MX2011005217A patent/MX2011005217A/es active IP Right Grant
- 2009-11-18 AU AU2009316708A patent/AU2009316708B2/en active Active
-
2011
- 2011-05-12 ZA ZA2011/03479A patent/ZA201103479B/en unknown
- 2011-05-19 CL CL2011001177A patent/CL2011001177A1/es unknown
- 2011-06-07 CO CO11069892A patent/CO6390043A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2012509337A (ja) | 2012-04-19 |
WO2010059717A2 (en) | 2010-05-27 |
AU2009316708A1 (en) | 2010-05-27 |
ZA201103479B (en) | 2012-02-29 |
CN102341125A (zh) | 2012-02-01 |
JP5685193B2 (ja) | 2015-03-18 |
EP2367572B1 (en) | 2018-08-29 |
CN102341125B (zh) | 2014-02-12 |
KR101748890B1 (ko) | 2017-06-19 |
KR20110092312A (ko) | 2011-08-17 |
NZ592984A (en) | 2012-12-21 |
WO2010059717A3 (en) | 2011-09-09 |
US20100125060A1 (en) | 2010-05-20 |
CL2011001177A1 (es) | 2011-09-16 |
EP2367572A2 (en) | 2011-09-28 |
ES2693700T3 (es) | 2018-12-13 |
AU2009316708B2 (en) | 2014-07-17 |
CA2743551A1 (en) | 2010-05-27 |
CO6390043A2 (es) | 2012-02-29 |
MX2011005217A (es) | 2011-06-01 |
BRPI0922041A8 (pt) | 2022-08-16 |
CA2743551C (en) | 2017-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0922041A2 (pt) | formulações compreendendo ceftiofur e cetoprofeno ou cetiofur e álcool benzílico. | |
BRPI0822929A2 (pt) | Composições compreendendo derivados de álcool benzílico e também compostos ativos antimicrobianos | |
NL2000620A1 (nl) | Aangedreven koppelversterker. | |
BRPI0812221A2 (pt) | Ácidos benzoilamino-indan-2-carboxílicos substituídos e compostos relacionados. | |
BRPI0908785A2 (pt) | Formulações herbicida | |
BRPI0822655A2 (pt) | Implemento e sistema para cuidado oral | |
BRPI0918652A2 (pt) | Composições farmacêuticas e métodos de libração relacionadas. | |
BRPI0820381A2 (pt) | Formulações farmacêuticas | |
DK2066354T3 (da) | Norovirus vaccine formuleringer | |
BRPI0814003A2 (pt) | Formulações de anticorpo | |
DK3072906T3 (da) | Antistofformulering | |
BRPI0920521A2 (pt) | combinação farmacêutica | |
BRPI0812970A2 (pt) | conjugados contendo espaçadores hidrofílicos | |
BRPI0911644A2 (pt) | Sistema anti micribiano | |
BRPI0814188A2 (pt) | Formulações | |
BRPI0914781A2 (pt) | Microbiocidas | |
BRPI0921654A2 (pt) | formulação farmacêutica | |
DE602008005054D1 (de) | Ultraschallsystem | |
BRPI0812228A2 (pt) | Combinações de substâncias ativas fungicidas | |
BRPI0911199A2 (pt) | microbiocidas | |
BRPI0917990A2 (pt) | formulação em gel antimicrobianas. | |
BRPI0922286A2 (pt) | composto de quinolona e composição farmacêutica. | |
BRPI0908455A2 (pt) | formulações de flibanserina | |
BRPI0916990A2 (pt) | Combinações inseticidas | |
BRPI0912656A2 (pt) | formulação farmacêutica sólida |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: MERIAL, INC. (US) |
|
B25A | Requested transfer of rights approved |
Owner name: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. (US) |